14 Jul AFR: Sector outperformance set to continue for a long time Posted at 18:00h in News by Rebecca James 0 Comments 0 Likes Atomo CEO, John Kelly talks about the need for a greater focus on converting healthcare research into commercial outcomes in this Australian Financial Review article. Read the full article > Tags: Atomo Diagnostics, Australian Financial Review, John Kelly